Sangamo Therapeutics (SGMO) 10-K2005 FY Annual report

Filed: 16 Mar 06, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: AFP, appeal, appealed, breach, CLI, constitute, DAS, disagree, disappointing, Dow, Eighty, Error, fold, frequency, glial, headcount, hemophilia, IC, ICH, Importantly, impracticable, inNote, inRule, interfering, interlocutory, IssueNo, liu, margaret, mento, mononuclear, NHLBI, Nordisk, Novo, Officr, onForm, PJB, pp, principle, progenitor, prophylactic, remeasured, request, requested, revert, revocation, revoked, revoking, Scrip, source, steven, strongly, teminate, TFsTM, TherapeuticTM, thisForm, thought, toRule, TSRI, uncured, understated, vol, ZFNsTM, ZPF

Removed: age, amortizing, annually, annum, assessed, assumed, bore, bridge, calculating, capitalized, chain, closed, comparing, compound, consolidate, consolidation, continuation, discount, discounting, disposed, effort, ensuing, exercisable, forgiven, forward, globin, goodwill, hemoglobin, hemolytic, housing, incremental, indefinite, inflation, intangible, invasive, Kingdom, lived, liver, loan, manufactured, obsolete, physiological, planning, premium, privately, procedure, profit, Promissory, purpose, rationalization, recoverable, reflected, render, representing, restructuring, retranslated, Rule, screen, sector, secured, shortfall, solubility, standardized, step, stroke, synergy, throughput, trait, transitional, unamortized, Universal, weighted

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

SGMO similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Registration Statements (Form S-8 No. 333-34196 and 333-64642) and in the Registration Statements (Form S-3 No. 333-113062 and 333-68066) and in the related prospectuses of Sangamo BioSciences, Inc. of our reports dated March 13, 2006, with respect to (1) the consolidated financial statements of Sangamo BioSciences, Inc., and (2) management’s assessment of the effectiveness of internal control over financial reporting and the effectiveness of internal control over financial reporting of Sangamo BioSciences, Inc., included in its Annual Report (Form 10-K) for the year ended December 31, 2005.

/s/ ERNST & YOUNG LLP

Palo Alto, California
March 13, 2006